Zobrazeno 71 - 80
of 1 797
pro vyhledávání: ''
Autor:
Parikshit Juvekar, Liangge Hsu, Wenya Linda Bi, Kyle C Wu, Ian F. Dunn, Thomas C. Harris, Michael A Mooney, Jonathan M. Cantalino, Ossama Al-Mefty, Phillip M. Devlin, Lucas L Possatti
Publikováno v:
Journal of Neuro-Oncology. 146:111-120
To evaluate surgical resection with brachytherapy placement as a salvage treatment in patients with recurrent high-grade meningioma who exhausted prior external beam treatment options. Single-center retrospective review of our institutional experienc
Autor:
Shahed N. Badiyan, Liam T. Kane, Jason K. Molitoris, Sonika Dahiya, Tony J. C. Wang, Alexander J. Lin, Deborah R. Smith, Jiayi Huang, Tim J. Kruser
Publikováno v:
Journal of Neuro-Oncology. 146:121-130
Practice patterns vary for adjuvant treatment of 1p/19q-codeleted oligodendroglioma patients. This study evaluates the outcomes of adjuvant (aRT) versus salvage radiation therapy (sRT) in a multi-institutional cohort. Oligodendroglioma patients with
Autor:
Paula Alcaide-Leon, Janine M. Lupo, Jennifer Clarke, Tracy Luks, Marisa Lafontaine, Javier Villanueva-Meyer, Hideho Okada
Publikováno v:
Journal of neuro-oncology, vol 146, iss 1
J Neurooncol
J Neurooncol
OBJECTIVES: Treatment-induced lesions represent a great challenge in neuro-oncology. The aims of this study were (i) to characterize treatment induced lesions in glioblastoma patients treated with chemoradiotherapy and heat-shock protein (HSP) vaccin
Autor:
Joerg C. Tonn, Rupert Egensperger, Annamaria Biczok, Christine Jungk, Christian Schichor, Christel Herold-Mende, Bogdana Suchorska, Andreas von Deimling
Publikováno v:
Journal of Neuro-Oncology. 145:469-477
For meningiomas, the 2016 revision of the WHO classification introduced brain invasion per se as a sufficient condition to classify as grade II. We analyzed whether meningiomas previously graded as WHO grade I differ in prognosis depending on the pre
Autor:
Jung-Il Lee, Kyung Rae Cho, Jung Won Choi, Ho Jun Seol, Doo-Sik Kong, Seung Won Choi, Do-Hyun Nam
Publikováno v:
Journal of Neuro-Oncology. 145:571-579
Stereotactic radiosurgery (SRS) is feasible for malignant glioma; however, delivering the optimal radiation dose with sufficient large-volume coverage is a major concern. We aimed to investigate the clinical efficacy and safety of fractionated SRS (f
Autor:
Marine Giry, Renzo Boldorini, Marc Sanson, Elena Trisolini, Dounia El Wardighi, Karima Mokhtari, Priscilla Bernardi
Publikováno v:
Journal of Neuro-Oncology. 145:241-245
Circumscribed gliomas -pilocytic astrocytomas (PA), gangliogliomas (GG), ependymomas (EP)- are mostly low-grade tumours but may progress to anaplasia and sometimes surgery can be challenging due to deep anatomical localization. Because of the high fr
Autor:
Christian Iorio-Morin, David Mathieu, Laurence Masson-Côté, Gabrielle Figueiredo, Rosalie Mercure-Cyr, Charles J Touchette
Publikováno v:
Journal of Neuro-Oncology. 145:551-559
Stereotactic radiosurgery (SRS) is a well-established treatment option for brain metastases (BM). Repeat SRS for progressive BM is an increasingly used paradigm, although little data is available to support this practice. The goal of this study was t
Autor:
Ashish H. Shah, Iahn Cajigas, Veronica Borowy, Ricardo J. Komotar, Nathalie Abitbol, Richard H. Epstein, Michael E. Ivan, Anil K. Mahavadi
Publikováno v:
Journal of Neuro-Oncology. 145:509-518
Reducing the time from surgery to adjuvant chemoradiation, by decreasing unnecessary readmissions, is paramount for patients undergoing glioma surgery. The effects of intraoperative risk factors on 30-day readmission rates for such patients is curren
Autor:
Oliver Schnell, Christina Hamisch, Elena Jansen, Maximilian I. Ruge, Stefan Grau, Dieter Henrik Heiland, Daniel Ruess, Roland Goldbrunner
Publikováno v:
Journal of Neuro-Oncology. 145:501-507
To provide detailed long-term data after initial observation for patients after histological confirmation of low grade (WHO II) gliomas according to molecular stratification. A series of 110 patients with watchful waiting strategy after initial surge
Publikováno v:
Journal of Neuro-Oncology
PurposeEcotropic viral integration site-1 (EVI1) is a transcription factor that contributes to the unfavorable prognosis of leukemia, some epithelial cancers, and glial tumors. However, the biological function of EVI1 in glioblastoma multiforme (GBM)